代谢障碍:卵巢衰老的黑暗面
Zhiyun Xue1, Xiuying Chen1, Jin Li2
1Obstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and School of Life Sciences, Fudan University, Shanghai, 200438, China; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai 200090, China.
Trends in molecular medicine
|June 7, 2024
概括
代谢障碍显著导致卵巢衰老,这是整个身体衰老的关键因素. 本综述涵盖了了解卵巢衰老的代谢调节方面的最新进展.
科学领域:
- 生殖生物学 生殖生物学
- 老年学是一门学科.
- 代谢研究的研究.
背景情况:
- 卵巢衰老是女性整体衰老过程的关键组成部分.
- 代谢功能障碍越来越被认为是卵巢衰老的重要驱动因素.
研究的目的:
- 审查最近在卵巢衰老的代谢调节方面的进展.
- 确定卵巢衰老和新陈代谢领域的关键挑战和未来方向.
主要方法:
- 关于新陈代谢调节和卵巢衰老的最新研究的文献综述.
- 综合有关分子和细胞机制的当前知识.
主要成果:
- 代谢失调,包括营养感应和能量代谢的干扰,直接影响卵巢功能并加速衰老.
- 特定的代谢途径和分子参与者已被确定为卵巢衰老的关键调节者.
结论:
- 准代谢途径是缓解卵巢衰老的有希望的治疗策略.
- 需要进一步的研究才能充分阐明新陈代谢和卵巢衰老之间的复杂相互作用.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Hormonal Control of the Ovarian Cycle
468
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
468
Menopause
155
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
155
Ovarian Cycle
1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Inborn Errors of Metabolism
155
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
155


